Home > Products > CD3 & MUC1
> Recombinant Anti-CD3 x Anti-MUC1 Bispecific Antibody (VHH-IgG)
Recombinant Anti-CD3 x Anti-MUC1 Bispecific Antibody (VHH-IgG) (CAT#: BSSG-385)
Recombinant Anti-CD3 x Anti-MUC1 Bispecific Antibody (VHH-IgG) is formed by an IgG and two VHH fragments. The VHHs from an anti-MUC1 antibody variable domain are respectively connected to the N terminus of the anti-CD3 IgG heavy chains or light chains to form VHH-(H)IgG or VHH-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Pancreatic cancer; Ovarian cancer; Breast cancer; Bile duct cancer (BDC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-MUC1 Bispecific Antibody (VHH-IgG) (BSSG-385). Click the button below to contact us or submit your feedback about this product.